FMS-74295-51290
4 vaccinations
5 coded responses
30 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 951 / CA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 2 — Pfizer-BioNTech
- 2021-03-22
-
2021-03-23
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: I am a type 1 diabetic and I wish this questionnaire had specific questions about other conditions so that different target audiences could get condition-tailored information about the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Lymphadenopathy, Pre-existing disease — Feeling: Good · Fatigue or tirednessFree text: Left armpit lymph node swelled up slightly, but no pain. Insulin resistance increasedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-06-23
- 2021-09-20
-
2021-10-14
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-22
-
2022-04-20
Dose 4 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-04-20
-
2022-04-21
Survey response — days 1–6 daily, dose 4MedDRA: Oropharyngeal pain — Feeling: Fair · Site: PainFree text: Slight sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2022-04-23
Survey response — days 1–6 daily, dose 4MedDRA: Menstruation irregular — Feeling: Fair · Fatigue or tirednessFree text: Period started 1.5 weeks earlyMedDRA releases: 2024-11 · check-in free text available
- 2022-04-24
- 2022-04-25
- 2022-04-29
- 2022-05-04
- 2022-05-13
- 2022-05-18
- 2022-05-27
- 2022-06-03
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: Malaise, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had lots of COVID symptoms that lasted 4-5 days, but tested negative on 5 home rapid tests and a rapid test at a urgent care clinicMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-21
Call successfulNot applicable - Accidental Reporting
- 2022-10-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-20 | Pfizer-BioNTech | Tetanus |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I am a type 1 diabetic and I wish this questionnaire had specific questions about other conditions so that different target audiences could get condition-tailored information about the vaccine
Systemic reaction (other): Left armpit lymph node swelled up slightly, but no pain. Insulin resistance increased
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Slight sore throat
Systemic reaction (other): Period started 1.5 weeks early
Release 12 — 3 months, dose 4
Symptoms: Had lots of COVID symptoms that lasted 4-5 days, but tested negative on 5 home rapid tests and a rapid test at a urgent care clinic
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Menstruation irregular | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release